CASI Pharmaceuticals (CASI) Leases (2021 - 2025)
Historic Leases for Pharmaceuticals (CASI) over the last 5 years, with Q2 2025 value amounting to $3.0 million.
- Pharmaceuticals' Leases fell 9982.64% to $3.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.0 million, marking a year-over-year decrease of 9982.64%. This contributed to the annual value of $3.5 million for FY2024, which is 9985.4% down from last year.
- As of Q2 2025, Pharmaceuticals' Leases stood at $3.0 million, which was down 9982.64% from $3.3 billion recorded in Q1 2025.
- Pharmaceuticals' Leases' 5-year high stood at $3.3 billion during Q1 2025, with a 5-year trough of $1.4 million in Q4 2022.
- For the 5-year period, Pharmaceuticals' Leases averaged around $977.5 million, with its median value being $9.1 million (2021).
- Its Leases has fluctuated over the past 5 years, first soared by 17100157.37% in 2023, then crashed by 9985.4% in 2024.
- Quarter analysis of 5 years shows Pharmaceuticals' Leases stood at $9.1 million in 2021, then plummeted by 84.65% to $1.4 million in 2022, then soared by 171001.57% to $2.4 billion in 2023, then plummeted by 99.85% to $3.5 million in 2024, then dropped by 12.71% to $3.0 million in 2025.
- Its last three reported values are $3.0 million in Q2 2025, $3.3 billion for Q1 2025, and $3.5 million during Q4 2024.